# Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE

> **NCT00787436** · PHASE3 · WITHDRAWN · sponsor: **The Cleveland Clinic**

## Conditions studied

- Gastrointestinal Hemorrhage
- Portal Hypertension

## Interventions

- **DRUG:** Thalidomide

## Key facts

- **NCT ID:** NCT00787436
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-05
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00787436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00787436, "Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00787436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*